February 23, 2018
Goldwater Institute Senior Policy Advisor Starlee Coleman appeared on C-SPAN’s Washington Week today to talk about the Right to Try, a law that protects terminally ill patients’ right to try investigational medicines that have not yet received full FDA approval.
Coleman explained that the law is a “completely patient-focused, bipartisan effort” with support from myriad organizations across the nation:
“One of the things that is so amazing about this issue is the types of people that come together to support it. In Texas, for example, when the state law was passing, the Texas AFL-CIO joined with the Catholic Bishops Conference and a number of other patient groups like the metastatic breast cancer community, ALS advocacy organizations, and others to come together to support this law.”
Today, Right to Try is law in 38 states, has passed the U.S. Senate unanimously, and is under consideration in the U.S. House.
Watch Coleman’s full interview here.
If you’re interested in learning more about Right to Try or becoming an advocate, visit RightToTry.org.
Sign up for the latest news, event updates, and more.
Help all Americans live freer, happier lives. Join the Goldwater Institute as we defend and strengthen freedom in all 50 states.
Donate NowSince 1988, the Goldwater Institute has been in the liberty business — defending and promoting freedom, and achieving more than 400 victories in all 50 states. Donate today to help support our mission.
Our attorneys defend individual rights and protect those who cannot protect themselves.
Need Help? Submit a case.